Symbol |
Name |
1060P11.3
|
killer cell immunoglobulin-like receptor, three domains, pseudogene
|
ACPP
|
acid phosphatase, prostate
|
AIF1
|
allograft inflammatory factor 1
|
ALDH2
|
aldehyde dehydrogenase 2 family (mitochondrial)
|
ANXA3
|
annexin A3
|
AQP1
|
aquaporin 1 (Colton blood group)
|
BID
|
BH3 interacting domain death agonist
|
CDH3
|
cadherin 3, type 1, P-cadherin (placental)
|
CFD
|
complement factor D (adipsin)
|
CHN2
|
chimerin 2
|
CILP
|
cartilage intermediate layer protein, nucleotide pyrophosphohydrolase
|
CITED2
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2
|
CLC
|
Charcot-Leyden crystal galectin
|
COL3A1
|
collagen, type III, alpha 1
|
COL4A5
|
collagen, type IV, alpha 5
|
CPE
|
carboxypeptidase E
|
CSF2RB
|
colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage)
|
CST3
|
cystatin C
|
CYBB
|
cytochrome b-245, beta polypeptide
|
CYBRD1
|
cytochrome b reductase 1
|
DEFA4
|
defensin, alpha 4, corticostatin
|
DNAJC12
|
DnaJ (Hsp40) homolog, subfamily C, member 12
|
EGFL6
|
EGF-like-domain, multiple 6
|
EIF5A
|
eukaryotic translation initiation factor 5A
|
EPHA4
|
EPH receptor A4
|
EREG
|
epiregulin
|
FAM129A
|
family with sequence similarity 129, member A
|
FAM171A1
|
family with sequence similarity 171, member A1
|
FGL2
|
fibrinogen-like 2
|
FHL1
|
four and a half LIM domains 1
|
FLRT2
|
fibronectin leucine rich transmembrane protein 2
|
FNBP1
|
formin binding protein 1
|
FOLR1
|
folate receptor 1 (adult)
|
G0S2
|
G0/G1 switch 2
|
GREB1
|
growth regulation by estrogen in breast cancer 1
|
GSN
|
gelsolin
|
GSTM3
|
glutathione S-transferase mu 3 (brain)
|
GUCY1B3
|
guanylate cyclase 1, soluble, beta 3
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
IFI6
|
interferon, alpha-inducible protein 6
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
IL2RG
|
interleukin 2 receptor, gamma
|
ISG15
|
ISG15 ubiquitin-like modifier
|
ITGAV
|
integrin, alpha V
|
ITM2A
|
integral membrane protein 2A
|
KCNJ16
|
potassium channel, inwardly rectifying subfamily J, member 16
|
KLF10
|
Kruppel-like factor 10
|
LCN2
|
lipocalin 2
|
LRRC17
|
leucine rich repeat containing 17
|
LST1
|
leukocyte specific transcript 1
|
LYZ
|
lysozyme
|
MAOA
|
monoamine oxidase A
|
MATN2
|
matrilin 2
|
MXRA5
|
matrix-remodelling associated 5
|
NEFH
|
neurofilament, heavy polypeptide
|
OLFM4
|
olfactomedin 4
|
PCP4
|
Purkinje cell protein 4
|
PLBD1
|
phospholipase B domain containing 1
|
PPP1R1A
|
protein phosphatase 1, regulatory (inhibitor) subunit 1A
|
PRKAR2B
|
protein kinase, cAMP-dependent, regulatory, type II, beta
|
PRKCI
|
protein kinase C, iota
|
PTGER3
|
prostaglandin E receptor 3 (subtype EP3)
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
|
PTPRD
|
protein tyrosine phosphatase, receptor type, D
|
RBP1
|
retinol binding protein 1, cellular
|
RGS10
|
regulator of G-protein signaling 10
|
RGS5
|
regulator of G-protein signaling 5
|
RNASE2
|
ribonuclease, RNase A family, 2 (liver, eosinophil-derived neurotoxin)
|
S100A7
|
S100 calcium binding protein A7
|
SAT1
|
spermidine/spermine N1-acetyltransferase 1
|
SCG2
|
secretogranin II
|
SEPP1
|
selenoprotein P, plasma, 1
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
SLC15A2
|
solute carrier family 15 (oligopeptide transporter), member 2
|
SLC35F2
|
solute carrier family 35, member F2
|
SPARCL1
|
SPARC-like 1 (hevin)
|
SQRDL
|
sulfide quinone reductase-like (yeast)
|
STEAP1
|
six transmembrane epithelial antigen of the prostate 1
|
STOM
|
stomatin
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
TFPI2
|
tissue factor pathway inhibitor 2
|
THBS4
|
thrombospondin 4
|
TMEM14B
|
transmembrane protein 14B
|
VTCN1
|
V-set domain containing T cell activation inhibitor 1
|
XIST
|
X inactive specific transcript (non-protein coding)
|